Eli Lilly weight-loss drug appears to suppress binge-eating signal, small study finds

Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...

Fake Ozempic, Zepbound: Booming despite serious health risks

Celebrity endorsements by Elon Musk and Serena Williams have pushed weight loss medication into the mainstream. Demand is so ...

Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid

GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

More Affordable Weight Loss Drugs May Be Coming Soon—But There Are A Couple Of Caveats

The Trump Administration recently announced lower prices on popular weight loss medications. Here's how this could work, plus ...

The Weight-Loss Craze Is About to Mint a Trillion-Dollar Company

The shift shows up clearly in market valuations. At the end of March 2024, Novo Nordisk was worth over $500 billion and Lilly ...
WBUR

How weight loss drugs impact the brain

Weight-loss drugs like Wegovy and Zepbound are highly effective for shedding pounds. But researchers at the Society for Neuroscience meeting say they are only beginning to understand how these ...

Novo Nordisk, Eli Lilly Weight Loss Price War Heats Up. Why It’s a Worry for the Stocks.

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.
US Weekly on MSN

Andy Richter Credits GLP-1 for ‘Dancing With the Stars’ Weight Loss: ‘Zepbound Helped a Lot’

Andy Richter got real about his Dancing With the Stars weight loss, attributing part of his slimdown to taking GLP-1 ...

Novo Nordisk Just Made a Big Move in the Weight Loss Drug Market. Should You Worry About Rival Eli Lilly?

Eli Lilly's tirzepatide acts on two hormonal pathways, so it's called a dual GIP/GLP-1 receptor agonist, and it entered the market as Mounjaro for Type 2 diabetes and as Zepbound for weight management ...